The patented system, detailed in Application No. 18/951,357, functions by monitoring coupled variables—the intersection of a user's trajectory, scheduled travel, and external toxins or diseases. By continuously analyzing these streams against a user’s pre-existing conditions and medication history, the AI generates proactive risk assessments rather than reactive reports. This approach aims to move beyond traditional health monitoring by anticipating potential hazards based on a user's future movements and environmental trends.

Donald Leka, CEO of the New York-based research firm, characterized the patent as a foundational addition to the company’s intellectual property portfolio. The underlying framework is intended to operate across multiple sectors, aiming to provide users with actionable intelligence in daily life. Jumptuit operates as part of The Jumptuit Group, an organization focused on Anticipatory Intelligence, which seeks to identify the antecedent elements of events to help individuals and policymakers mitigate risks before they manifest.